Selected research
Market Structure
Global Bifidobacterium Animalis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bifidobacterium Animalis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bifidobacterium Animalis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifidobacterium Animalis include ADM, ATCC, Chr. Hansen, Creative Biolabs, DuPont Nutrition & Biosciences, Fengchen Group, Microbiologics, Morinaga and SynBalance, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Bifidobacterium Animalis output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Bifidobacterium Animalis by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Bifidobacterium Animalis market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bifidobacterium Animalis and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bifidobacterium Animalis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidobacterium Animalis market size, projected growth trends, production technologies, key applications, and end-use industries.
Bifidobacterium Animalis Segment by Company
ADM
ATCC
Chr. Hansen
Creative Biolabs
DuPont Nutrition & Biosciences
Fengchen Group
Microbiologics
Morinaga
SynBalance
BGI Nutri
Wecare Probiotics
Yili Group
Wisbiom (Beijing) Biotechnology
Bifidobacterium Animalis Segment by Type
Bifidobacterium Animalis Subsp. Lactis
Bifidobacterium Animalis Subsp.
Bifidobacterium Animalis Segment by Application
Medicine and Health Products
Food
Clinical Auxiliary Treatment
Animal Feed
Other
Bifidobacterium Animalis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Animalis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Animalis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Animalis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bifidobacterium Animalis market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifidobacterium Animalis industry.
Chapter 3: Detailed analysis of Bifidobacterium Animalis market competition landscape. Including Bifidobacterium Animalis manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Bifidobacterium Animalis by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Bifidobacterium Animalis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bifidobacterium Animalis Subsp. Lactis
- Bifidobacterium Animalis Subsp.
Applications
- Medicine and Health Products
- Food
- Clinical Auxiliary Treatment
- Animal Feed
- Other
Companies covered
- ADM
- ATCC
- Chr. Hansen
- Creative Biolabs
- DuPont Nutrition & Biosciences
- Fengchen Group
- Microbiologics
- Morinaga
- SynBalance
- BGI Nutri
- Wecare Probiotics
- Yili Group
- Wisbiom (Beijing) Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bifidobacterium Animalis Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Bifidobacterium Animalis Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Bifidobacterium Animalis Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Bifidobacterium Animalis Market Dynamics
- 2.1 Bifidobacterium Animalis Industry Trends
- 2.2 Bifidobacterium Animalis Industry Drivers
- 2.3 Bifidobacterium Animalis Industry Opportunities and Challenges
- 2.4 Bifidobacterium Animalis Industry Restraints
3 Bifidobacterium Animalis Market by Manufacturers
- 3.1 Global Bifidobacterium Animalis Production Value by Manufacturers (2021-2026)
- 3.2 Global Bifidobacterium Animalis Production by Manufacturers (2021-2026)
- 3.3 Global Bifidobacterium Animalis Average Price by Manufacturers (2021-2026)
- 3.4 Global Bifidobacterium Animalis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidobacterium Animalis Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bifidobacterium Animalis Manufacturers, Product Type & Application
- 3.7 Global Bifidobacterium Animalis Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifidobacterium Animalis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifidobacterium Animalis Players Market Share by Production Value in 2025
- 3.8.3 2025 Bifidobacterium Animalis Tier 1, Tier 2, and Tier 3
4 Bifidobacterium Animalis Market by Type
- 4.1 Bifidobacterium Animalis Type Introduction
- 4.1.1 Bifidobacterium Animalis Subsp. Lactis
- 4.1.2 Bifidobacterium Animalis Subsp.
- 4.2 Global Bifidobacterium Animalis Production by Type
- 4.2.1 Global Bifidobacterium Animalis Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bifidobacterium Animalis Production by Type (2021-2032)
- 4.2.3 Global Bifidobacterium Animalis Production Market Share by Type (2021-2032)
- 4.3 Global Bifidobacterium Animalis Production Value by Type
- 4.3.1 Global Bifidobacterium Animalis Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bifidobacterium Animalis Production Value by Type (2021-2032)
- 4.3.3 Global Bifidobacterium Animalis Production Value Market Share by Type (2021-2032)
5 Bifidobacterium Animalis Market by Application
- 5.1 Bifidobacterium Animalis Application Introduction
- 5.1.1 Medicine and Health Products
- 5.1.2 Food
- 5.1.3 Clinical Auxiliary Treatment
- 5.1.4 Animal Feed
- 5.1.5 Other
- 5.2 Global Bifidobacterium Animalis Production by Application
- 5.2.1 Global Bifidobacterium Animalis Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bifidobacterium Animalis Production by Application (2021-2032)
- 5.2.3 Global Bifidobacterium Animalis Production Market Share by Application (2021-2032)
- 5.3 Global Bifidobacterium Animalis Production Value by Application
- 5.3.1 Global Bifidobacterium Animalis Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bifidobacterium Animalis Production Value by Application (2021-2032)
- 5.3.3 Global Bifidobacterium Animalis Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ADM
- 6.1.1 ADM Company Information
- 6.1.2 ADM Business Overview
- 6.1.3 ADM Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.1.4 ADM Bifidobacterium Animalis Product Portfolio
- 6.1.5 ADM Recent Developments
- 6.2 ATCC
- 6.2.1 ATCC Company Information
- 6.2.2 ATCC Business Overview
- 6.2.3 ATCC Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.2.4 ATCC Bifidobacterium Animalis Product Portfolio
- 6.2.5 ATCC Recent Developments
- 6.3 Chr. Hansen
- 6.3.1 Chr. Hansen Company Information
- 6.3.2 Chr. Hansen Business Overview
- 6.3.3 Chr. Hansen Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.3.4 Chr. Hansen Bifidobacterium Animalis Product Portfolio
- 6.3.5 Chr. Hansen Recent Developments
- 6.4 Creative Biolabs
- 6.4.1 Creative Biolabs Company Information
- 6.4.2 Creative Biolabs Business Overview
- 6.4.3 Creative Biolabs Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.4.4 Creative Biolabs Bifidobacterium Animalis Product Portfolio
- 6.4.5 Creative Biolabs Recent Developments
- 6.5 DuPont Nutrition & Biosciences
- 6.5.1 DuPont Nutrition & Biosciences Company Information
- 6.5.2 DuPont Nutrition & Biosciences Business Overview
- 6.5.3 DuPont Nutrition & Biosciences Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.5.4 DuPont Nutrition & Biosciences Bifidobacterium Animalis Product Portfolio
- 6.5.5 DuPont Nutrition & Biosciences Recent Developments
- 6.6 Fengchen Group
- 6.6.1 Fengchen Group Company Information
- 6.6.2 Fengchen Group Business Overview
- 6.6.3 Fengchen Group Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.6.4 Fengchen Group Bifidobacterium Animalis Product Portfolio
- 6.6.5 Fengchen Group Recent Developments
- 6.7 Microbiologics
- 6.7.1 Microbiologics Company Information
- 6.7.2 Microbiologics Business Overview
- 6.7.3 Microbiologics Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.7.4 Microbiologics Bifidobacterium Animalis Product Portfolio
- 6.7.5 Microbiologics Recent Developments
- 6.8 Morinaga
- 6.8.1 Morinaga Company Information
- 6.8.2 Morinaga Business Overview
- 6.8.3 Morinaga Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.8.4 Morinaga Bifidobacterium Animalis Product Portfolio
- 6.8.5 Morinaga Recent Developments
- 6.9 SynBalance
- 6.9.1 SynBalance Company Information
- 6.9.2 SynBalance Business Overview
- 6.9.3 SynBalance Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.9.4 SynBalance Bifidobacterium Animalis Product Portfolio
- 6.9.5 SynBalance Recent Developments
- 6.10 BGI Nutri
- 6.10.1 BGI Nutri Company Information
- 6.10.2 BGI Nutri Business Overview
- 6.10.3 BGI Nutri Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.10.4 BGI Nutri Bifidobacterium Animalis Product Portfolio
- 6.10.5 BGI Nutri Recent Developments
- 6.11 Wecare Probiotics
- 6.11.1 Wecare Probiotics Company Information
- 6.11.2 Wecare Probiotics Business Overview
- 6.11.3 Wecare Probiotics Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.11.4 Wecare Probiotics Bifidobacterium Animalis Product Portfolio
- 6.11.5 Wecare Probiotics Recent Developments
- 6.12 Yili Group
- 6.12.1 Yili Group Company Information
- 6.12.2 Yili Group Business Overview
- 6.12.3 Yili Group Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.12.4 Yili Group Bifidobacterium Animalis Product Portfolio
- 6.12.5 Yili Group Recent Developments
- 6.13 Wisbiom (Beijing) Biotechnology
- 6.13.1 Wisbiom (Beijing) Biotechnology Company Information
- 6.13.2 Wisbiom (Beijing) Biotechnology Business Overview
- 6.13.3 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Production, Value and Gross Margin (2021-2026)
- 6.13.4 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Product Portfolio
- 6.13.5 Wisbiom (Beijing) Biotechnology Recent Developments
7 Global Bifidobacterium Animalis Production by Region
- 7.1 Global Bifidobacterium Animalis Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Bifidobacterium Animalis Production by Region (2021-2032)
- 7.2.1 Global Bifidobacterium Animalis Production by Region (2021-2026)
- 7.2.2 Global Bifidobacterium Animalis Production Forecast by Region (2027-2032)
- 7.3 Global Bifidobacterium Animalis Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Bifidobacterium Animalis Production Value by Region (2021-2032)
- 7.4.1 Global Bifidobacterium Animalis Production Value by Region (2021-2026)
- 7.4.2 Global Bifidobacterium Animalis Production Value by Region (2027-2032)
- 7.5 Global Bifidobacterium Animalis Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Bifidobacterium Animalis Production Value (2021-2032)
- 7.6.2 Europe Bifidobacterium Animalis Production Value (2021-2032)
- 7.6.3 Asia-Pacific Bifidobacterium Animalis Production Value (2021-2032)
- 7.6.4 South America Bifidobacterium Animalis Production Value (2021-2032)
- 7.6.5 Middle East & Africa Bifidobacterium Animalis Production Value (2021-2032)
8 Global Bifidobacterium Animalis Consumption by Region
- 8.1 Global Bifidobacterium Animalis Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Bifidobacterium Animalis Consumption by Region (2021-2032)
- 8.2.1 Global Bifidobacterium Animalis Consumption by Region (2021-2026)
- 8.2.2 Global Bifidobacterium Animalis Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Bifidobacterium Animalis Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Bifidobacterium Animalis Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Bifidobacterium Animalis Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Bifidobacterium Animalis Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Bifidobacterium Animalis Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Bifidobacterium Animalis Value Chain Analysis
- 9.1.1 Bifidobacterium Animalis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bifidobacterium Animalis Production Mode & Process
- 9.2 Bifidobacterium Animalis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifidobacterium Animalis Distributors
- 9.2.3 Bifidobacterium Animalis Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst